Healthcare -
Biotechnology - NASDAQ - US
$ 1.05
2.94 %
$ 57.8 M
Market Cap
-0.59
P/E
PRLD - TOTAL CURRENT ASSETS
Total Current Assets PRLD - Prelude Therapeutics Incorporated
236 M
LAST VALUE
-10.65%
2 YEAR CAGR
72.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR